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Background
Early right ventricular (RV) failure after insertion of an
implantable left ventricular assist device (LVAD) is asso-
ciated with a poor prognosis and increased mortality.
Improved assessment of RV volumes with cardiovascular
magnetic resonance imaging (CMR) prior to LVAD place-
ment may lead to more optimal patient selection.
Methods
Patients were referred for cardiovascular magnetic reso-
nance imaging prior to LVAD placement. We assessed
the association of mortality to pre-LVAD right ventricu-
lar end systolic volume index (RVESVI), right ventricular
end diastolic volume index (RVEDVI), left ventricular
ejection fraction (LVEF) by CMR. Right ventricular
stroke work index (RVSWI) was determined by pre-
LVAD right heart catheterization.
Results
We studied 15 consecutive patients (mean age, 54 ±12
years; 54% male) who received HVAD (60%) and Heart-
Mate II (40%) LVADs for a diagnosis of dilated cardio-
myopathy (57%) and ischemic cardiomyopathy (43%).
26.7% of patients had an implantable defibrillator (ICD)
at the time of the MRI (figure 1), without any device-
related complications or issues with image quality. A
total of 3 deaths occurred during a median follow-up of
19 months (range, 3 to 31 months). By univariate analy-
sis (table 1), mortality was significantly associated with
increased RVESVI (116.9 ml ± 32.8 vs. 65.1 ml ± 25.6;
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Figure 1 4-chamber (left) and short-axis (right) turbo-GRE images of right ventricle in pre-LVAD patient with ICD. Arrows indicate minimal ICD
lead artifact.
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p = 0.01) and RVEDVI (140.4 ml ± 21 vs. 86.6 ml ±
19.1; p = 0.001) when assessed prior to implantation of
LVAD by CMR. There was no observed association in
mortality with the more typical risk predictors of LVEF
or RVSWI assessed prior to LVAD placement.
Conclusions
Increased RVESVI and RVEDVI assessed by CMR prior
to implantation of LVADs is a predictor of post-implant
mortality, while more typical measures such as LVEF was
not. CMR acquisition and RV image quality was not hin-
dered by implantable cardiac devices. Evaluation of RV
volumes by CMR may improve risk-stratification and
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Table 1 Cardiovasuclar Magnetic Resonance imaging
measurement of study population
Dead (n=3) Alive (n=12) p Value
RVEDVI (ml/ m2) 140.0±21.1 86.6±19.1 0.001
RVESVI (ml/ m2) 116.9±32.8 65.1±25.6 0.01
RVSV (ml) 45.8±42.8 40.8±23.9 0.784
RVEF (%) 17.1±15.1 27±18.9 0.42
Cl (ml/ min) 934.1±831.9 2770.9±1632.7 0.087
LVEF (%) 12.9±5.1 18.4±9.8 0.367
RVSWI (mmHg ml/m2) 342±151.7 441.7±132.1 0.275
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